Clinical Trial Update: Retreatment of Recurrent Dupuytren's Contractures [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing retreatment for recurrent Dupuytren's contractures has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dupuytren Disease

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Dupuytren's Disease | Phase 4 | Status: COMPLETED | Results posted: 2015-02-20